Hyperliquid Strategies Q2 2026 Earnings Report

Hyperliquid Strategies EPS Results

• Actual EPS: -$7.43
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Hyperliquid Strategies Revenue Results

• Actual Revenue: $0.50 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Hyperliquid Strategies Announcement Details

• Quarter: Q2 2026
• Date: 2/11/2026
• Time: After Market Closes
• Conference Call Date: Wednesday, February 11, 2026
• Conference Call Time: 8:00AM ET

Hyperliquid Strategies (NASDAQ:PURR) is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK.

Hyperliquid Strategies Q2 2026 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: Since close the company has deployed about $140 million — roughly $130M to buy HYPE (~5M tokens at an average ~ $26) and ~$10M to repurchase ~3M shares (avg $3.42), leaving ~$125M of capital and ~17.5M HYPE held.
• Positive Sentiment: Management highlighted strong platform traction: Hyperliquid was #1 in perp volume and open interest, processed huge on‑chain volumes in 2025, and January revenues were $79 million (a run‑rate implying ~ $240M for Q1 if sustained).
• Negative Sentiment: HSI reported a $318 million net loss for the six months ended Dec 31, 2025, driven by a ~$169M accounting loss on contributed HYPE, an unrealized post‑close HYPE decline (~$93M), and a $35.6M Sonnet R&D write‑off, plus an $18M deferred tax liability.
• Neutral Sentiment: Company launched a public dashboard to show adjusted NAV and trading multiple in near real time, emphasized an MNAV‑driven buy/sell treasury framework (CEO has final authority), plans to keep HYPE fully staked now and is evaluating a validator role medium‑term.

Presentation

[Robert Diamond, Director of Corporate Affairs at Hyperliquid Strategies]

Good morning, and welcome to Hyperliquid Strategies Second Fiscal Quarter Earnings Conference Call. My name is Robert Diamond, and I am Director of Corporate Affairs for Hyperliquid Strategies. Participating in today's call are David Schamis, Chief Executive Officer, and Brett Beldner, Chief Financial Officer. David will review the company's vision and strategy, as well as the current business environment and market positioning. This will be followed by Brett, who will review the company's financial performance. As a reminder, this conference is being recorded. We ask that you please hold all questions until the completion of the formal remarks, at which time you'll be given instructions for the question and answer session. Before we begin, please note that the comments during today's call and the accompanying presentation contain forward-looking information. All statements other than statements of historical facts are considered forward-looking statements.

[Robert Diamond, Director of Corporate Affairs at Hyperliquid Strategies]

All forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from the results discussed in the forward-looking statements. Some of these risks and uncertainties are identified and discussed in the company's filings with the SEC. In addition, information in this call and the presentation regarding Hyperliquid and its operations is based on information that has been publicly disseminated by Hyperliquid and has not been independently verified by the company. We ask that you take a moment to read the disclaimers at the beginning of the slides that accompany this presentation, as they contain important information.

[David Schamis, CEO at Hyperliquid Strategies]

Thank you, Rob. This is David Schamis. I'm gonna start on Page 5. Just to remind everybody, we are a digital asset treasury company, and our job is to hold the HYPE token. When we closed on December second, investors contributed both HYPE tokens to us and cash. Since then, we have used our cash to both buy back our stock, as well as to buy HYPE tokens in the market. We continue to be very impressed with the speed at which Hyperliquid is moving to continue to grow its existing crypto business, and maybe even more exciting, to bring real-world assets on chain. Two Fridays ago, when silver had a massive trading day, 2% of the world's trading volume happened on Hyperliquid, and that was after it only being available on the Hyperliquid platform for about three weeks. Incredibly impressive.

[David Schamis, CEO at Hyperliquid Strategies]

If you go to Page 6, just to remind everybody, HSI, Hyperliquid Strategies Inc., is currently the largest DAT for HYPE by a pretty wide margin. I have said before, many times that unlike Bitcoin, and other widely available tokens, HYPE is still not easily accessed, particularly in the United States, and our main job, at least for now, is to enable that access for investors on a major U.S. exchange. As we will continue to discuss, we try to be as efficient as possible with our capital, primarily focused on the NAV per share accretion that we can achieve with our activities. We will continue to explore opportunities to enhance our yield while taking as little additional risk as possible. HYPE is already a very volatile asset, and we are not looking to turn HSI into a VC fund.

[David Schamis, CEO at Hyperliquid Strategies]

On Page 7, people have seen this group before, but we're very proud of the world-class group we have put together to help advance the Hyperliquid, Hyperliquid ecosystem and to grow our NAV per share. The most valuable thing that we think we can do for the ecosystem is to help different players and people in the system access the traditional financial system. There aren't too many senior leaders in the traditional financial world that someone in our group can't get access to. Bob was the CEO of Barclays. I frequently point out that Barclays was the only major U.S. or U.K. bank to never take government money. Eric Rosengren was a career Fed guy who most recently served as the president of the Boston Fed and member of the Fed's Open Market Committee.

[David Schamis, CEO at Hyperliquid Strategies]

Larry Leibowitz was the President and COO of the New York Stock Exchange when it was merged into ICE. Tom King was the former head of the corporate investment bank in Barclays, and more importantly, a managing director at Salomon Brothers in the nineties, when both myself and Jeroen, our COO, were lowly analysts in the investment bank. And lastly, we have partnered with some of the top participants in the crypto market who give us TradFi guys some invaluable insights into the crypto world, and most notably, Paradigm is a co-sponsor of the deal with us here. If you go to Page 8, we are executing aggressively on our strategy here. A few things to point out, two analysts have started to cover HSI. Hopefully, they're on this call, and we expect more to come in the not-so-distant future.

[David Schamis, CEO at Hyperliquid Strategies]

We think that, as part of spreading the awareness of Hyperliquid, this is done both with things like being on TV, and being very public, but it's also one-on-ones with investors, going on podcasts, being at conferences, et cetera. I happen to be sitting in Hong Kong right now at a crypto conference. One of the more interesting things that have happened since we announced this deal last July, needless to say, we have talked to lots of people who find what we're doing interesting. We've spent some time with a very large, very well-known high-frequency trading firm, U.S.-based, and amazingly, they told us that they are not able to buy the HYPE token directly themselves, even though they are quite engaged in crypto trading, and that's because it is traded on a DEX-...

[David Schamis, CEO at Hyperliquid Strategies]

and their current compliance program wouldn't let them invest directly on a DEX. That, to me, proved just how much value we could be bringing right now by creating a DAT for Hyperliquid. If you go to Page 10, this is a bit of a, bit of a high level on the global financial system. Needless to say, I could drone on here for a long time, but I'm not going to. The basic concept is we have all heard more and more that crypto, excuse me, that real world assets are gonna be moving on-chain. But how exactly that's gonna happen has been an open question in a lot of places, and we think Hyperliquid is a big part of that.

[David Schamis, CEO at Hyperliquid Strategies]

The other thing I want to point out, over the last 10 years or so, there have been crypto maximalists who think the whole world is going on-chain, and we're all gonna be buying bread in the store with Bitcoin overnight. There have also been quite a bit of people from the financial services world in particular, who think it's all going to zero, and this is all just a, just a joke. For years, we have been sitting somewhere in the middle of those things, and we think the world is moving to being in the middle of those things. I think it is obvious that crypto is real, trillions of dollars of market cap, and will be here for a long time, if not forever, and innovations that come out of it will be very, very important.

[David Schamis, CEO at Hyperliquid Strategies]

On the other hand, I don't think we're all gonna be buying bread tomorrow with Bitcoin, at least not in the United States. If you go to Page 11. On Page 11, there are a couple of general observations I'd like to make. First, it is difficult to get consistent data, and when it comes to crypto, there is often no single source of truth. There's also a lack of standardized definitions that we have to cull through to figure out how we think about a lot of these things. There's a lot to cover, and new developments literally pop up every day in this world. 2025 saw solid performance of Hyperliquid as both a perp DEX as well as a blockchain. The perp DEX excelled in the first half and was, for a long time, on track to be the single largest fee-generating blockchain.

[David Schamis, CEO at Hyperliquid Strategies]

The blockchain setup proved efficient and saw huge volumes processed and attracted many new users rapidly. Some important innovations turned into real revenue generators very quickly. If we go to Page 12, some numbers around this. From a very small base in the fourth quarter of 2024, Hyperliquid saw massive revenue growth through 2025, and even though the fourth quarter was less than the third quarter, so far in the first quarter of 2026, we're seeing a very strong rebound. January had $79 million of revenue, which was approximately double December, and on that rate, we'd be at about $240 million of revenue for the first quarter. Meanwhile, Hyperliquid is the number one DEX in perp volume, the number one perp open interest, with more than 150,000 active weekly addresses.

[David Schamis, CEO at Hyperliquid Strategies]

If you go to page 13, this is a very important page, and it shows a number of things that are happening in the Hyperliquid system. Over the last 12 months, they've rolled out all these things, and I'm gonna briefly run through them. First one, Builder Codes. This is allowing other people, like Phantom, to use their distribution to tap into the perp liquidity on Hyperliquid, thus adding more volume and more fees to the platform. The second one, HIP-3. This allows others to create their own perp exchange front ends for whatever real-world assets they see opportunities in, without the time and the cost of building the back-end nuts and bolts of a central limit order book. The third is HLP.

[David Schamis, CEO at Hyperliquid Strategies]

This allows users to share collateral across positions, which is so important to market makers in the platform, ultimately bringing more liquidity to the platform. And fourth, HIP-4, extending the idea of HIP-3 in allowing others to create their own front ends in both options and prediction markets. I think for so many companies we're all used to in the Tradfi world, if they achieved one of these things in a 12-month period, they would be very proud of themselves. Hyperliquid is gonna do all four of these things. That is extremely, extremely impressive. One thing I always talk about as a way to visualize how important these, these things are, I'll talk about HIP-4 for a second. And imagine being a startup company looking to raise money to compete with Polymarket.

[David Schamis, CEO at Hyperliquid Strategies]

You're sitting in a room with a venture capitalist, and they ask you how long it'll take and how much money it will cost for you to build a back-end processing system to compete with Polymarket. The answer before HIP-4 would have been: It'll take a lot of money and a lot of time. That would be a serious deterrent to someone putting money into that new venture capital startup. Instead, now, that company can say, "We're gonna use the infrastructure provided by HIP-4, and we're gonna entirely focus on the front end," meaning the marketing, the finding customers, and offering interesting things, and creating liquidity. The entire back end can be handled by the HIP, by HIP-4, which is extremely impressive. Onto Page 14. These are a couple nice headlines. There's been many, many more, obviously.

[David Schamis, CEO at Hyperliquid Strategies]

I will say last spring, when we started seriously investigating Hyperliquid, very few people in the traditional finance industry had any idea what Hyperliquid was. Today, even with all the progress that it has made, it is still relatively unknown in the circles that we normally run in.... A big part of our job is to continue to bring awareness to this amazing blockchain and the technology associated with it to the mainstream financial world. The more people we talk to, the more time we spend on it, the more impressed people are, and the more amazed that this is being created and growing right under their nose. Lastly, let's go to Page 15.

[David Schamis, CEO at Hyperliquid Strategies]

This graph shows perfectly how while so many people are talking about all the useful things that are being built on chain, the HYPE token has true utility in that 99% of the revenues of the blockchain are being used to repurchase and burn the tokens. Versus everything else in the crypto world today, there is literally no comparison between all of them combined and what Hyperliquid has done in this regard. That being said, let's switch now. Let's go to Page 17. This is a little bit how we think about our treasury strategy. This is meant to be a framework. This is an art, not a science.

[David Schamis, CEO at Hyperliquid Strategies]

The main point here, the main value we can add is that over time, we want to be able to buy the HYPE tokens and possibly buy our own shares to take advantage of varying market conditions to ultimately create NAV per share accretion for our shareholders. That is our number one goal. To state the obvious, this chart, I think, speaks for itself, but when our MNAV is high, we will be selling shares into the market, thus accreting our NAV per share. When our MNAV is low, we'll be buying back our shares from the market, thus accreting our NAV per share. When we believe that HYPE is trading below its fundamental value, we will be buying the HYPE tokens, and when we believe that HYPE is trading above its fundamental value, we will consider selling.

[David Schamis, CEO at Hyperliquid Strategies]

Just for the avoidance of doubt, right now, where we have been, and pretty much where we have been since close, we believe that HYPE is well below its real fundamental intrinsic value, and we are, needless to say, very bullish. A simple thing I would tell you is when we think of things like PE, price to earnings, HYPE trades well below the S&P 500 and even more further below other comparables in the crypto world. It's not even close, actually. You go to Page 18. This is a bit of an update of what we have done so far. These numbers are as of last week. We will be going forward, posting on a dashboard, all the things we do with a one-week lag. So it's perfectly appropriate today that we're showing these numbers with about a one-week lag.

[David Schamis, CEO at Hyperliquid Strategies]

But since we closed, we have deployed about $140 million. Of that $140 million, approximately $10 million have been in buying back our own shares. We did that at an average price of $3.42. We've repurchased over 3 million shares. That brings our adjusted fully diluted share count down to about 150 million. We have bought about $130 million in tokens. Our average price is a little under $26 per token. We have purchased about 5 million tokens, and that brings our amount of HYPE held to about 17.5 million HYPE tokens. We have about $125 million of capital remaining.

[David Schamis, CEO at Hyperliquid Strategies]

That is both for a treasury deployment, also buying back, stock if the opportunity came about. That excludes some capital we are reserving for operating the business. Obviously, we're a public company, and there are costs associated with that. We also have an ELOC in place to do additional share issuances, as we talked about earlier, when we see the opportunity. With that, I'm gonna move to Page 20, and I'm gonna pass on to Brett to talk in more detail about some of the financial metrics.

[Brett Beldner, CFO at Hyperliquid Strategies]

Thank you, David, and good morning, everyone. Now I'd like to discuss our financial performance for the first six months of our fiscal 2026 reporting year. Page 20 provides a summary of our performance. As you will see, HSI's results are driven by two key factors: the change in the value of the HYPE token between signing and the end of the reporting period, and the acquisition of Sonnet. Going back, the terms of the overall transaction provided that we received commitments from investors in both cash and HYPE tokens of approximately $888 million. The value of the HYPE contributions was fixed at signing at around $46.37 a token. Upon closing the acquisition of Sonnet in December, the price of the tokens had declined to around $32.86 a token.

[Brett Beldner, CFO at Hyperliquid Strategies]

The difference between the two resulted in an accounting loss on the HYPE commitment of around $169 million. The acquisition of Sonnet was treated for accounting purposes as an asset acquisition. The excess purchase price paid for Sonnet, including associated transaction costs over the fair value of both the tangible and intangible net assets acquired, represented in-process research and development costs of $35.6 million. These costs were written off at closing, as they were not deemed to have any future use....The remainder of our pre-tax operating performance primarily related to the period after the transaction closed through December 31. We recognized interest income from our cash and cash equivalents and staking income from our HYPE tokens for a total of approximately $1.4 million.

[Brett Beldner, CFO at Hyperliquid Strategies]

We record our HYPE tokens at fair value, so any changes in the value of our HYPE holdings are reflected through income. Due to the decline in the HYPE token price post-closing, an unrealized loss of approximately $93 million was generated for the time between the transaction closing and December thirty-first. SG&A and R&D expenses represent operating costs for the period, which include establishing the $1 billion equity line, getting the company up and running, as well as normal operating costs of both the HYPE treasury business as well as the Sonnet legacy business. We also note that there was a tax impact of the transaction in our results. The transaction was structured in a manner that allowed the company to receive contributed HYPE tokens at an investor's tax basis.

[Brett Beldner, CFO at Hyperliquid Strategies]

The difference between our tax basis and the fair value of the tokens on December 31st resulted in an $18 million deferred tax liability, with a corresponding deferred tax expense reflected in our income statement. The net result is a $318 million loss for the six months ending December 31, 2025. Moving on to Page 21 and our balance sheet, I'll spend a minute or two focusing on the material items. There are two material assets on our balance sheet at the end of the quarter: cash and cash equivalents and our HYPE tokens. Upon closing, we received about $300 million of cash from investors and approximately $10 million from Sonnet.

[Brett Beldner, CFO at Hyperliquid Strategies]

This cash has been used during the period to purchase $9 million of HYPE tokens, buy back approximately $10 million of common stock, pay closing costs, and pay operating expenses. As of December 31, we had approximately $282 million of cash and cash equivalents remaining, a portion of which, as David discussed, we will maintain to ensure we have sufficient funds for our operations over the foreseeable future, and the remainder is eligible to be used for our treasury strategy. The $327 million HYPE digital assets balance represents the fair value of the approximately 12.9 million HYPE tokens that we owned as of December 31. This consists of the HYPE tokens that we received as contributions from our investors, HYPE rewards earned from staking, and any HYPE purchased as part of our treasury strategy.

[Brett Beldner, CFO at Hyperliquid Strategies]

On the liability side, we have no debt obligations other than short-term liabilities that resulted from either the transaction or in the normal course of business. The deferred tax liability represents our current estimate of the tax obligation that would exist if we were to sell all of our HYPE assets based on the price of the HYPE token on December 31. Please note, we currently have no intent to sell our HYPE, but are required to recognize this under GAAP. Our stockholders' equity represents the value of all the shares and warrants issued in the transaction, less the operating losses from our financial performance and deducting share repurchases.

[Brett Beldner, CFO at Hyperliquid Strategies]

So overall, while the price performance of the HYPE token was not as we would have liked during the reporting period, the size of our cash balance on hand, combined with the price of HYPE in January, left us in a very strong position to execute our treasury strategy. Moving on from our financial results to Page 22, we spent a lot of time since closing, speaking to investors, analysts, and looking at other digital asset treasury companies. The one key message that we received is that other than for SEC reporting, there is a lack of transparency in the market about companies' digital asset holdings, cash positions, net asset values, et cetera.

[Brett Beldner, CFO at Hyperliquid Strategies]

We debated internally amongst the senior management team, as well as the board, as to how best provide useful information to the public, but yet not prejudice our ability to be in the market for both HYPE and our shares. The result of those discussions is illustrated on Page 21. This slide represents a dashboard that we, we will be putting up on our website that contains an illustration of several key factors that we, as senior management, use to implement our treasury strategy, and therefore wanted to share that with the public. Walking through an example, we consider the following: the fair value of our HYPE portfolio, the current market capitalization of PER, our company stock, including any common stock equivalents.

[Brett Beldner, CFO at Hyperliquid Strategies]

Common stock equivalents currently include the number of shares that our preferred stock is convertible into and will include any dilutive securities that may exist in the future. These items are then incorporated into the analysis, which we will show in two ways. On the left side, we take our stockholders' equity or net asset value from the last reporting period and roll it forward through the following: We subtract cash spent from operations, add the amount of cash we've received from issuing equity, and subtract the amount of cash that we've deployed in our treasury strategy. We then remove the balances of our HYPE portfolio and current deferred tax liability estimate from the last reporting period and update them based on the current HYPE token price to get an adjusted net asset value number.

[Brett Beldner, CFO at Hyperliquid Strategies]

On the right side, we provide our current cash balance and our HYPE portfolio at fair value based on the current token price, and subtract out our estimated deferred tax liability and adjust for other movements to get to the same adjusted net asset value. The adjusted net asset value is then compared to the current share price to get a trading multiple of adjusted NAV, as illustrated on the slide here and will be included on the website. Some of these factors, such as the HYPE price and our stock price, will update real time, and other updates, such as the execution of our treasury strategy, will be updated on a weekly basis, one week in arrears. We believe that this information is important for people to understand our business and our performance more often than once a quarter, when we provide our required SEC reporting.

[Brett Beldner, CFO at Hyperliquid Strategies]

We hope you will as well. We expect the website will be up and running with this dashboard today. Now I'll turn it back over to David to wrap up the presentation.

[David Schamis, CEO at Hyperliquid Strategies]

Thanks, Brett. I'll make two last sets of comments. The first, just to beat a dead horse on this Page 22, we thought it was important to show this both ways, the left and the right. There were some people who wanted just a simple analysis on the right: How much cash do we have? How much tokens do we, do we own? Deferred tax liability that they can add back, and what does that come out to? And there are some people who are gonna be much more careful and want to foot back to our financial statements, and that's what we do on the left, and obviously, they both come to the same number, which is the key thing. We are not gonna take everybody through all the pages in the appendix.

[David Schamis, CEO at Hyperliquid Strategies]

You can go through those on your own, but I do want to point out one page that we think is very important. Page 31, we believe to be an important page. This is where we equate the tokens outstanding on HYPE to what we consider to be how an analyst would look at a regular way public company. It's amazing how much time we spend talking to people about this, and it is a topic that is not normally something spent a lot of time when dealing with, as I say, regular way public companies. If you look at the column on the left, we start with 1 billion tokens. This is the initial supply, and this is the most that could ever be issued in the future.

[David Schamis, CEO at Hyperliquid Strategies]

To start with, we deduct things that have been reserved that to generally help develop the platform and participation in trading and staking to drive the ecosystem. This includes future emissions, Hyper Foundation, and community grants. These may be issued in the future, and they'll only be issued in the future if they're associated with specific growth initiatives that believe to add to the value of the total ecosystem, but they have not been issued yet. The second bucket would be tokens that have been permanently burned, either through buybacks from the assistant fund or fees on HyperCore and HyperEVM. Those are gone forever. What's left, the outstanding token supply, which we have up here, is what we would equate to a regular way public company when thinking about shares outstanding. Now, of that, about half is to the core contributors. These are the founders of Hyperliquid.

[David Schamis, CEO at Hyperliquid Strategies]

Some of these are unlocked, meaning they're vested and allowed to be sold and traded. Some are not yet unlocked, but for our purposes, we assume it is all available, because over time, they will unlock. We think the likelihood of any of these unvested, not vesting are pretty low. And then the last is the circulating supply. That's the amount that you can buy and sell today. And when you add those two things together, that is what we consider to be the outstanding token supply, which equates to about a $15 billion market cap if we were comparing this to what I'd call a regular public company. This is a topic we'll be talking about quite a bit. It'll come up a lot.

[David Schamis, CEO at Hyperliquid Strategies]

I am curious and eager to hear comments from others about how they feel about token supply and if they think we're thinking about this the wrong way. With that, that concludes our formal presentation, and we would like to go to any questions and answers from listeners.

[Operator]

Thank you. At this time, if you would like to ask a question, please click on the Raise Hand button, which can be found on the black bar at the bottom of your screen. When it is your turn, you will receive a message on your screen from the host, allowing you to talk, and then you will hear your name called. Please accept, unmute your audio, and ask your question. We will wait one moment to allow the queue to form. Our first question comes from James McIlree with Chardan. Please unmute your line and ask your question.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

... Thank you. Good morning. In slide eight-

[David Schamis, CEO at Hyperliquid Strategies]

Hello.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

Hello, can you hear me?

[David Schamis, CEO at Hyperliquid Strategies]

Yep, we hear you fine.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

Great, thanks. In slide eight, you have a line that says you're exploring validator opportunities. Can you discuss what's going into that, potential timing, cost, and the thought process as to why you would or wouldn't do it?

[David Schamis, CEO at Hyperliquid Strategies]

Yeah. I think that's, you know, one of our goals, certainly long term, but probably more like medium term, is to be more and more engaged in the Hyperliquid ecosystem. I think being a validator would be one way we could do that. The other thing is that it is important going forward that we are have an operating business beyond just holding the tokens for all the various reasons we all know, being a validator checks that box. So we are, we are working through that. I don't have a particular timeline. Like, I, I don't wanna say it'll be on a particular date, 'cause we, you know, this is something you don't want to roll out till you're absolutely perfect.

[David Schamis, CEO at Hyperliquid Strategies]

There's not a lot of room for error in being a validator, but we think this will be something in the... I would call it the medium term. I think the cost of getting this up and running will not be significant. It'll be something. It's not, nothing in this world is free. But it won't be, it won't move the needle any meaningful way. We're not gonna, lik e, spend a bunch of money to buy something and put a bunch of goodwill on the balance sheet. That's not even remotely possible.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

That's great. Thank you. That's helpful. And then, secondly, the thought process on buying the stock or buying the token, I know what you're saying, but can you put a little bit more specificity around that? That is, and I'm making up numbers now, so you need MNAV to be greater than 1.1 before you start issuing stock, or you need MNAV less than, again, making up numbers, 0.9, in order to buy the stock. Can you put maybe a little bit of boundaries on where you would be buying tokens versus buying stock relative to MNAV?

[David Schamis, CEO at Hyperliquid Strategies]

Yeah, look, as I said before, we consider this an art, not a science. Like, we're not gonna sit here and say, at, you know, 0.91, we won't be buying back our stock, but at 0.89, we will be. And the other thing is that it depends on how long you're at these various levels. If you sit at 0.89, just to use your example, for five minutes, we're not necessarily gonna be pouncing into the market. If we're there for five days or five weeks, there's more likelihood we would. So again, you know, I would say on one hand, we're specifically not gonna put, you know, those kind of specific numbers out there.

[David Schamis, CEO at Hyperliquid Strategies]

On the other hand, I would have to say the range you use, the above 1.1 and below 0.9, is certainly where we get focused on both ends of that, if that makes sense to you. Again, it doesn't mean we're gonna hit the button at 1.11, but that's where we really start paying attention and focusing ourselves. At 0.01 or at 0.99, you know, we're not gonna sit there and be super focused on either one of those.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

Yeah, I get it. That makes sense.

[David Schamis, CEO at Hyperliquid Strategies]

Hopefully, that's helpful. I'm not trying to be evasive. I'm actually just telling you the actual truth. This is how we go about it. You know, this is not meant to be an algorithm. It's meant to be a thought process.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

That makes, that makes eminent sense. Thank you. I appreciate that. And then lastly, so is that an investment committee decision, or is that a CEO decision, or how does that, how does that decision get made to say, "Okay, the MNAV is at levels we find interesting, so we're going to be buying stock or buying, or buying the token?

[David Schamis, CEO at Hyperliquid Strategies]

Yeah. I would say it's two things. It's a constant discussion and debate among the management team. It is frequent updates to the board around our thinking around this. The board is not involved in every purchase. That wouldn't be feasible, but I don't think any purchase we do would surprise any board member when we do it. But ultimately, the decision is with me, the CEO.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

Understood. Thank you,

[David Schamis, CEO at Hyperliquid Strategies]

Yeah.

[James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan]

Yeah, I'll cede the floor and let others ask questions.

[David Schamis, CEO at Hyperliquid Strategies]

Perfect. Thanks for joining, and thanks for breaking the ice on the questions.

[Operator]

Our next question comes from Gareth Gacetta with Cantor. Please unmute your line and ask your question.

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

Hi, guys. Can you hear me all right?

[David Schamis, CEO at Hyperliquid Strategies]

Yeah, we hear you great, Gareth. How are you?

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

Great, good. Thanks for taking the question. I just wanted to kind of double dive on the staking for the quarter. Could you maybe provide an update on what percentage of your HYPE holdings are staked with validators? And I don't know if you've given kind of a framework on how to think about that going forward, if you kind of expect to maintain a certain percent staked versus liquid.

[David Schamis, CEO at Hyperliquid Strategies]

Yeah. Brett, you can correct me if I'm wrong here, but 100% is staked. At the moment, 100% is staked with Anchorage, our custody provider. And I think we plan on having a 100% staked all the time, unless there's, you know... Obviously, circumstances might change sometimes, but the steady state we expect is to be a 100%.

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

Got it. Thank you.

[Brett Beldner, CFO at Hyperliquid Strategies]

That is, that is correct as to where we are at the moment. Of course, as David said earlier, you know, we do evaluate other opportunities that may come in to use the HYPE tokens, but as David also explained, we are not planning on being a hedge fund. So in order to do something that generates a return that's acceptable with risk, it would have to meet our, you know, standards, and as a result, currently, the plan is to continue to stake until something that we're comfortable that is better comes along.

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

Gotcha. Just a quick follow-up to, I know it's kind of early, but the ecosystem just announced HIP-4 and kind of prediction markets. So I'm wondering if you could just kind of give, like, your overall thoughts, high level, and, and how you think you might end up playing in that space.

[David Schamis, CEO at Hyperliquid Strategies]

Yeah, look, we're excited about HIP-4. There was talk about it, some speculation over the last months. So, I don't think... We weren't surprised, but we're excited about it, and it just shows the advancements here and the idea that we're gonna be, it's both, it's both options and prediction markets. Prediction markets have certainly garnered a lot of attention in the world lately. But on the other hand, you know, the amount of options that are traded in this world and the amount of revenue generated from options being traded in this world so far, dwarf what's going on in prediction markets. It's not even close, but both of them are really great to see. It's not out yet.

[David Schamis, CEO at Hyperliquid Strategies]

I think that the Hyperliquid team is still in the building mode there, but I'm glad they announced it, and I'm glad that the world is getting prepared for it. From our point of view, you know, I'm not sure we have any particular plan to do anything particularly interesting day one. We're evaluating, as we said before, evaluating things we potentially do with our token around HIP-3. Haven't done anything yet. I always tell people that when we think about these things, when we think about committing our capital to anything other than staking, whether sort of the Twitter world likes it or not, we move at sort of TradFi speeds. We're not moving at crypto speeds, you know, and that's sort of the world we live in and how we think about it.

[David Schamis, CEO at Hyperliquid Strategies]

But we're careful with our capital, but obviously want to generate the best yields we can.

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

Totally. Maybe if I could sneak one last one in.

[David Schamis, CEO at Hyperliquid Strategies]

Sure.

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

I just wanted to get your thoughts on the Clarity Act passage. I know it's kind of back and forth, and it seems like we're butting heads a little bit, but some outlooks seem to be like we're gaining progress. So just wanted to kinda get your take and then what types of catalysts that might bring going forward.

[David Schamis, CEO at Hyperliquid Strategies]

Yeah, look, I don't think we have any particular knowledge that's not well known to everyone around timing or likelihood of passage. I had heard in the sort of late fall, early winter, that there were some people who were quite well-placed that were absolutely certain the president would be signing at the end of 2025. That didn't happen, obviously. I think prognosticators now are thinking it'll be done in the spring, which would be great. Again, it's really hard to know whether it's gonna happen or not. I'm sure Polymarket can tell us the odds of it happening, and that's probably as good as any guess we're gonna have. As far as what it means for Hyperliquid, I still think it's somewhat unclear. I don't think perps are gonna be explicitly allowed in the Clarity Act.

[David Schamis, CEO at Hyperliquid Strategies]

It's possible, but I don't expect that. I don't necessarily expect a DEX to be explicitly allowed in the U.S. in the Clarity Act. On the other hand, we do think there may be paths in the act for regulatory action over time to pave the way for these things. I would say that's sort of our hope. But, you know, beyond that, I don't think we know anything you guys don't know, and we're hoping it gets done. I think as a voter and as a crypto market participant, I'm hoping come November, this isn't, like, some major partisan issue in the November elections, that this is behind us.

[David Schamis, CEO at Hyperliquid Strategies]

That would be bad, and I think that actually I think both parties are hoping that that's true, that it is not a major partisan issue.

[Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor]

Okay, great. Thanks for taking all the questions, and congrats on the first earnings call.

[David Schamis, CEO at Hyperliquid Strategies]

Yep. Thanks for, thanks for joining, and thanks for the good questions.

[Operator]

That concludes the question and answers portion of today's call. I'll now hand the call back to Hyperliquid Strategies team for any written questions and closing remarks.

[David Schamis, CEO at Hyperliquid Strategies]

Look, we're happy everyone joined. Appreciative for the questions, appreciative for everyone focusing on this, and we look forward to continued success. Just to one last point, as we said before, we expect by the end of the day today, our dashboard to be on the website, and I think that'll be a nice look into how we see the NAV on a sort of day-to-day, minute-by-minute basis. Thanks, everyone, and look forward to doing this again.

[Brett Beldner, CFO at Hyperliquid Strategies]

Thank you.

Participants

Executives

• Brett Beldner, CFO
• David Schamis, CEO
• Robert Diamond, Director of Corporate Affairs

Analysts

• Gareth Gacetta, Equity Research Associate in Crypto and Digital Assets and Equity Research at Cantor
• James McIlree, Equity Research Analyst in Healthcare and Biotechnology at Chardan